Steven Simonson is SVP, Chief Medical Officer of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 17,440 shares of WINT, which is worth approximately $12,208. The most recent transaction as insider was on Aug 23, 2023, when has been sold 15,867 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4K
0% 3M change
0% 12M change
Total Value Held $12,208

Steven Simonson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
BUY
Grant, award, or other acquisition
-
15,867 Added 47.64%
17,440 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
-
100 Reduced 5.98%
1,573 Common Stock
Mar 15 2022
BUY
Open market or private purchase
$5,000 $1.0 p/Share
5,000 Added 5.64%
83,602 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
66,300 Added 45.76%
78,602 Common Stock
Mar 25 2021
BUY
Open market or private purchase
$4,875 $3.25 p/Share
1,500 Added 10.87%
12,302 Common Stock
SS

Steven Simonson

SVP, Chief Medical Officer
Warrington, PA

Track Institutional and Insider Activities on WINT

Follow WINDTREE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

News

Receive news related to WINDTREE THERAPEUTICS INC

Track Activities on WINT